Mechanical Circulatory Support for High-Risk Percutaneous Coronary Intervention
Purpose of Review This review will focus on the indications of mechanical circulatory support (MCS) for high-risk percutaneous coronary intervention (PCI) and then analyze in detail all MCS devices available to the operator, evaluating their mechanisms of action, pros and cons, contraindications, and clinical data supporting their use. Recent Findings Over the last decade, the interventional cardiology arena has witnessed an increase in the complexity profile of the patients and lesions treated in the catheterization laboratory. Patients with significant comorbidity burden, left ventricular dysfunction, impaired hemodynamics, and/or complex coronary anatomy often cannot tolerate extensive percutaneous revascularization. Therefore, a variety of MCS devices have been developed and adopted for high-risk PCI. Summary Despite the variety of MCS available to date, a detailed characterization of the patient requiring MCS is still lacking. A precise selection of patients who can benefit from MCS support during high-risk PCI and the choice of the most appropriate MCS device in each case are imperative to provide extensive revascularization and improve patient outcomes. Several new devices are being tested in early feasibility studies and randomized clinical trials and the experience gained in this context will allow us to provide precise answers to these questions in the coming years..
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:26 |
---|---|
Enthalten in: |
Current cardiology reports - 26(2024), 4 vom: 26. Feb., Seite 233-244 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Moscardelli, Silvia [VerfasserIn] |
---|
Links: |
Volltext [lizenzpflichtig] |
---|
BKL: | |
---|---|
Themen: |
Extracorporeal membrane oxygenation |
Anmerkungen: |
© The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. |
---|
doi: |
10.1007/s11886-024-02029-2 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
SPR055417019 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | SPR055417019 | ||
003 | DE-627 | ||
005 | 20240405064707.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240405s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/s11886-024-02029-2 |2 doi | |
035 | |a (DE-627)SPR055417019 | ||
035 | |a (SPR)s11886-024-02029-2-e | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 610 |q VZ |
084 | |a 44.85 |2 bkl | ||
100 | 1 | |a Moscardelli, Silvia |e verfasserin |4 aut | |
245 | 1 | 0 | |a Mechanical Circulatory Support for High-Risk Percutaneous Coronary Intervention |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. | ||
520 | |a Purpose of Review This review will focus on the indications of mechanical circulatory support (MCS) for high-risk percutaneous coronary intervention (PCI) and then analyze in detail all MCS devices available to the operator, evaluating their mechanisms of action, pros and cons, contraindications, and clinical data supporting their use. Recent Findings Over the last decade, the interventional cardiology arena has witnessed an increase in the complexity profile of the patients and lesions treated in the catheterization laboratory. Patients with significant comorbidity burden, left ventricular dysfunction, impaired hemodynamics, and/or complex coronary anatomy often cannot tolerate extensive percutaneous revascularization. Therefore, a variety of MCS devices have been developed and adopted for high-risk PCI. Summary Despite the variety of MCS available to date, a detailed characterization of the patient requiring MCS is still lacking. A precise selection of patients who can benefit from MCS support during high-risk PCI and the choice of the most appropriate MCS device in each case are imperative to provide extensive revascularization and improve patient outcomes. Several new devices are being tested in early feasibility studies and randomized clinical trials and the experience gained in this context will allow us to provide precise answers to these questions in the coming years. | ||
650 | 4 | |a Percutaneous coronary intervention |7 (dpeaa)DE-He213 | |
650 | 4 | |a High-risk percutaneous coronary intervention |7 (dpeaa)DE-He213 | |
650 | 4 | |a Mechanical circulatory support |7 (dpeaa)DE-He213 | |
650 | 4 | |a Intra-aortic balloon pump |7 (dpeaa)DE-He213 | |
650 | 4 | |a Impella |7 (dpeaa)DE-He213 | |
650 | 4 | |a Extracorporeal membrane oxygenation |7 (dpeaa)DE-He213 | |
650 | 4 | |a TandemHeart |7 (dpeaa)DE-He213 | |
700 | 1 | |a Masoomi, Reza |e verfasserin |4 aut | |
700 | 1 | |a Villablanca, Pedro |e verfasserin |4 aut | |
700 | 1 | |a Jabri, Ahmad |e verfasserin |4 aut | |
700 | 1 | |a Patel, Ankitkumar K. |e verfasserin |4 aut | |
700 | 1 | |a Moroni, Francesco |e verfasserin |4 aut | |
700 | 1 | |a Azzalini, Lorenzo |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Current cardiology reports |d Springer US, 1999 |g 26(2024), 4 vom: 26. Feb., Seite 233-244 |w (DE-627)SPR022871691 |w (DE-600)2094155-9 |x 1534-3170 |7 nnns |
773 | 1 | 8 | |g volume:26 |g year:2024 |g number:4 |g day:26 |g month:02 |g pages:233-244 |
856 | 4 | 0 | |u https://dx.doi.org/10.1007/s11886-024-02029-2 |m X:VERLAG |x 0 |z lizenzpflichtig |3 Volltext |
912 | |a GBV_SPRINGER | ||
912 | |a SSG-OLC-PHA | ||
936 | b | k | |a 44.85 |q VZ |
951 | |a AR | ||
952 | |d 26 |j 2024 |e 4 |b 26 |c 02 |h 233-244 |